Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
74 participants
INTERVENTIONAL
2016-11-30
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Glucose Monitoring in People With Diabetes on Dialysis
NCT06657508
Effect of Dialysis Glucose Bath on Glycemic Control in Hemodialysis (HD)
NCT01359904
STUDY OF GLUCOSE IN DIALYSIS WATER WITH REGARD TO BLOOD PRESSURE AND QUALITY OF LIFE
NCT00278057
Continuous Glucose Monitoring in Patients With Diabetes on Peritoneal Dialysis
NCT06069518
Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis
NCT01049152
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Teaching: individual and Teaching: disease process.
2. Control of hyperglycemia and Control of hypoglycemia.
3. Teaching: prescription drugs (prescription drugs, was carried out focusing on oral hypoglycemic agents and insulin)
4. Teaching: psychomotor skills ( was performed with a view to the management and application of insulin). In case of use oral antiglycemic agent the Teaching: prescription drugs and control of hyperglycaemia and hypoglycemia was repeated
5. Teaching: Foot care.
6. Teaching: activity / prescribed exercises. After the completion of the six intervention patients were assessed for outcome classification the study will contemplate a 6 months washout between the NOC assessment ( end of interventions and final assessment)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Patients have not received any special intervention, the follow up care was the standard care for the specific clinic
No interventions assigned to this group
Intervention
After initial allocation the select patient received six educational interventions selected from Nursing Intervention Classification (NIC)
Educational
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* over 18 years old
* literate,
* who accept to participate in the study by signing a Term of Consent Free and Clarified
Exclusion Criteria
* total amaurosis,
* degenerative neurological diseases,
* score less than 20 in the Mini Mental State Examination
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pontificia Universidade Católica do Rio Grande do Sul
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ana Elizabeth Prado Lima Figueiredo
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudia Capellari, Master
Role: PRINCIPAL_INVESTIGATOR
Pontificia Universidade Católica do Rio Grande do Sul
Ana Figueiredo, PhD
Role: PRINCIPAL_INVESTIGATOR
Pontificia Universidade Católica do Rio Grande do Sul
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pontificia Universidade Católica Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EnfDiaTrial
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.